An academic paper on “High-throughput screening of peptides using mRNA/cDNA display,” conducted jointly by res […]
Our article about laboratory automation was published in Experimental Medicine Vol.39 No.1 2021 実験医学「新型コロナで変わる […]
MOLCURE’s work on drug discovery using AI and robotics was featured in the Nikkei Business Daily. MOLCUREのAIとロ […]
Our CEO Ryu Ogawa will speak at the “KBIC Pitch Vol. 1” on Feb 3, 15:29 JST. 2月3日開催の「KBIC Pitch vol,１（ 資金調達/協業 […]
MOLCURE has been selected for Microsoft for Startups, a start-up program supported by Microsoft. Microsoft for […]
An interview with our CEO Ryu Ogawa was published in the web magazine EL BORDE. ウェブマガジン EL BORDEに、CEO 小川のインタビュ […]
Our CCO Shoji Ihara will speak at the “Business matching for companies specializing in medical and health care […]
We will be exhibiting at PharmaLab EXPO 2020 / Interphex Week at Makuhari Messe in Chiba, Japan from November […]
Our CTO Yutaro Kyono will speak at the “Message from a Venture Companies Online Corporate Matching in Shinkawa […]
Our CEO Ryu Ogawa will speak about Drug Development at the CPhI Japan Webinar on Nov 13, 14:15 JST. 11月13日開催の中 […]